Login
$NXTC
$6.68 +$0.28 (4.37%) Live

$NXTC SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
13 Nov 2026 SCHEDULE 13G/A
13 Nov 2026 Form 4
10 Nov 2026 10-Q
10 Nov 2026 8-K: Results of Operations and Financial Condition

Advancing Toward Stockholder Approval of Proposed Merger with Avere Therapeutics Supported by Approximately $820 Million of Committed Financing

09 Nov 2026 Form 4: ADAR1 Capital Management, Llc, 10% owner and 1 other

Bought 1,024 shares ($5.22K) · Bought 3,662 shares ($18.7K)

06 Nov 2026 EFFECT
06 Nov 2026 424B3
06 Nov 2026 S-4/A
02 Nov 2026 S-4/A
30 Oct 2026 8-K: Departure/Election of Directors or Officers; Compensation

On October 26, 2026 NextCure, Inc. (the “Company”) determined that the employment of Dr. Udayan Guha, M.D., Ph.D., Chief Medical Officer and a named executive officer of the Company, will be terminated effective October 31, 2026, in cont...

27 Oct 2026 Form 4: ADAR1 Capital Management, Llc, 10% owner and 1 other

Bought 5,626 shares ($27.2K) · Bought 1,672 shares ($8.42K) · Bought 3,553 shares ($18.1K)

20 Oct 2026 SCHEDULE 13G
01 Oct 2026 S-4/A
25 Sep 2026 425
25 Sep 2026 8-K: Other Events

Petitioner NextCure, Inc. (“NextCure” or the “Company”), by and through its undersigned counsel, brings this petition pursuant to 8 Del. C. § 205, seeking to have this Court validate a potentially defective corporate act as follows:

03 Sep 2026 8-K: Entry into a Material Definitive Agreement

This NINTH AMENDMENT TO LEASE AGREEMENT (“this Ninth Amendment”) is dated as of August 28, 2026 (“Effective Date”), by and between ARE-8000/9000/10000 VIRGINIA MANOR, LLC, a Delaware limited liability company, having an address at 26 Nor...

18 Aug 2026 S-4
14 Aug 2026 SCHEDULE 13G
14 Aug 2026 SCHEDULE 13G/A

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support